Work With Data
search

Novolife in the news

Updated: 164d ago

Analyze the latest Novolife news, with a current neutral sentiment polarity (0.28) or the entire set.

Latest news

Here are the latest news on this scope:

Novo's Ozempic Notches Approval for Kidney Disease, Widening Use

Read on: Bloomberg link
164d ago

Defense, Novo and Nestle: 2024 Highs and Lows in European Stocks

Read on: Bloomberg link
194d ago

Eli Lilly and Novo Want to Shake off Ozempic Copycats. Are They Ready To Meet Demand?

Read on: The Wall Street Journal link
236d ago

Novo's Ozempic Reduced Opioid Overdose Risk, Research Shows

Read on: Bloomberg link
290d ago

Lilly Gains in Obesity Race With Novo as Supplies Expand

Read on: Bloomberg link
338d ago

Novo's Supply Crunch, Germany's Pain: EMEA Earnings Week Ahead

Read on: Bloomberg link
344d ago

Beyond Novo and Eli Lilly: Watch these biotech and weight loss drug names, fund manager says

Read on: CNBC News link
349d ago

Wegovy maker Novo inks $16.5 billion acquisition of Catalent to boost supply

Read on: Axios link
523d ago

Why Obesity Drug Coverage Doesn't Matter (Yet) for Lilly and Novo

Read on: The Wall Street Journal link
528d ago

Lilly trades at a premium to Ozempic maker Novo as obesity drugs boom. Here's why, analyst says

Read on: CNBC News link
610d ago

Extract data

Extract all the news on this scope:

dataset_white Full dataset

Visualize data

Here are some available charts on these news:

Evolution through time

Distribution of sources in the news

Distribution of sections in the news

Sentiment polarity through time